Fundamentals of Chemotherapy Immunotherapy
Administration EXAM (2026) UPDATE Verified
Questions And Answers | Latest Already Graded A+
UPDATE |2026
Who can mix Chemotherapy?
Pharmacist, Pharmacy tech, MD/DO, qualified RN
Who can administer chemotherapy?
Registered Nurses with specialized education, prep and training.
See specific state laws and statutes
How often is chemo competency reassessed>
Annual continuing ed and competency assessment is recommended
What is the dose verification process?
-confirm plan with patient
-two practitioners verify: drug name, dose, volume, rate, route,
expiration date, appearance
-document verification in chart
,What PPE is required for IV Chemotherapy?
-Gloves: two pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy (tumor burden)
Chemo BEFORE primary treatment (common in breast and colon)
Adjuvant therapy
Chemo AFTER primary treatment (common in solid tumor)
Bone Marrow
soft, sponge-like tissue in center of most bones, produce WBC, RBC,
and platelets.
Myelosuppression
bone marrow activity is decreased, causing less RBC, WBC and
Platelets.
Myeloablation
severe myelosuppression
, Induction phase
initial phase, typically in hospital, intended myelosuppression
Consolidation phase (intensification/postremission therapy)
after successful induction, kills cancer cells left in body (ex
radiation, stem cell transplant)
Synergy
when one chemo drug helps another work better at the same time
Complete response
no identifiable cancer present for at least one month or longer
Partial response
Measurable tumor reduced by 50% for at least one month with no
new tumors
Stable disease
Tumor size reduced by less than 50% or less than 25% increase in
growth
Administration EXAM (2026) UPDATE Verified
Questions And Answers | Latest Already Graded A+
UPDATE |2026
Who can mix Chemotherapy?
Pharmacist, Pharmacy tech, MD/DO, qualified RN
Who can administer chemotherapy?
Registered Nurses with specialized education, prep and training.
See specific state laws and statutes
How often is chemo competency reassessed>
Annual continuing ed and competency assessment is recommended
What is the dose verification process?
-confirm plan with patient
-two practitioners verify: drug name, dose, volume, rate, route,
expiration date, appearance
-document verification in chart
,What PPE is required for IV Chemotherapy?
-Gloves: two pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy (tumor burden)
Chemo BEFORE primary treatment (common in breast and colon)
Adjuvant therapy
Chemo AFTER primary treatment (common in solid tumor)
Bone Marrow
soft, sponge-like tissue in center of most bones, produce WBC, RBC,
and platelets.
Myelosuppression
bone marrow activity is decreased, causing less RBC, WBC and
Platelets.
Myeloablation
severe myelosuppression
, Induction phase
initial phase, typically in hospital, intended myelosuppression
Consolidation phase (intensification/postremission therapy)
after successful induction, kills cancer cells left in body (ex
radiation, stem cell transplant)
Synergy
when one chemo drug helps another work better at the same time
Complete response
no identifiable cancer present for at least one month or longer
Partial response
Measurable tumor reduced by 50% for at least one month with no
new tumors
Stable disease
Tumor size reduced by less than 50% or less than 25% increase in
growth
